Product
CC-92328
1 clinical trial
1 indication
Indication
Multiple MyelomaClinical trial
A Phase 1, Multi-center, Open-label, Dose Finding Study of CC-92328 in Subjects With Relapsed and/or Refractory Multiple MyelomaStatus: Active (not recruiting), Estimated PCD: 2025-07-01